Skip to content

Feasibility Study of Cortical Recording Depolarizations in Brain-injured Patients, and Their Use as Biomarkers of New Lesions.

Feasibility Study of Cortical Recording Depolarizations in Brain-injured Patients, and Their Use as Biomarkers of New Lesions.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04585503
Acronym
SD-ICU
Enrollment
20
Registered
2020-10-14
Start date
2021-01-01
Completion date
2023-04-07
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Lesion, Head Trauma, Subarachnoid Hemorrhage

Keywords

subdural or intra cortical implanted electrodes, CNS monitor, brain lesions

Brief summary

The progression of brain lesions after severe head trauma or subarachnoid hemorrhage results from extra cranial aggression which is well controlled in intensive care and intracranial aggression which is less well known and therefore less well managed. The detection of events that can generate new lesions from intracranial monitoring is limited and late once the lesions are irreversible. Invasive cortical depolarizations (SD) can be observed using cortical electrodes and an acquisition system having access to the usually filtered DC signal (0 to 1 Hz). SD are observed at the onset of a new attack of the cortex and spread widely away from the site of aggression. During their propagation, SD generate a significant metabolic demand, and can cause ischemic injury, particularly after meningeal or post-traumatic hemorrhage. SDs are therefore both a marker of new lesion and a mechanism of progression of primary lesions. Yet this type of monitoring is only performed in some expert centers around the world. The analysis of the feasibility and safety of the placement of cortical electrodes in this indication is therefore an essential step to study the clinical benefit of individualized management on the basis of this monitoring.

Interventions

DEVICEElectrode implantation

The intervention consist in implanting 6 electrodes in subdural or intra cortical position and monitor the central nervous system activity. This monitoring will be additional to the usual monitoring.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient \> 18 year old * Patients admitted in neurological reanimation unit for brain lesions after severe head trauma or subarachnoid hemorrhage and requesting a intracranial monitoring or a surgery (evacuation of a hematoma, treatment of an aneurysm, external ventricular bypass). * Patients affiliated to a social security system * Patient having been informed and having signed the Consent form OR Close to the patient who has been informed and signed the Consent form OR third party certificate then close consent for further study.

Exclusion criteria

* Patient with scalp acute infection * Pregnant or nursing women * Contre-indication to intracranial surgery * Patient with not corrected coagulation disorder * Patient treated with NSAIDS * Patient treated with under platelet antiaggregants * Patient under legal protection, guardianship, curators * patients under legal protection * Patient participating in a study who may interfere with this study. * people under duress psychiatric care,

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of Invasive cortical depolarization (SD) recorded in a non-expert center with subdural or intra cortical implanted electrode and central nervous system monitoring.18 monthsThe feasibility of the study will be objectivized by the availability of a signal of sufficient quality to be exploited, with or without SD: namely a signal without artifact on more than 30% of the recording period on at least 3 electrodes on 6 for at least 12h. The signal analysis should, at least twice a day, allow intervening with the patient if necessary.

Secondary

MeasureTime frameDescription
Evaluation of electrode implantation safety.during electrode extractionSafety will be evaluated recording severe and non-severe adverse events during electrode extraction.
Evaluation of temporality between Invasive cortical depolarization and intracranial hypertension.during monitoring, maximum 15 daysproportion of patient with Invasive cortical depolarization before, during and after intracranial hypertension.
Evaluation of temporality between Invasive cortical depolarization and oxygen in tissue decreasing pressureduring monitoring, maximum 15 daysproportion of patient with Invasive cortical depolarization before during and after oxygen in tissue decreasing.
Evaluation of electrode implantation safetyduring implantation procedureSafety will be evaluated recording severe and non-severe adverse events during implantation procedure.
Evaluation of temporality between Invasive cortical depolarizations and EEG change of rhythm.during monitoring, maximum 15 daysproportion of patient with Invasive cortical depolarization before, during and after EEG change of rhythm.
Evaluation of temporality between Invasive cortical depolarization and detection of a new cerebral lesion.during monitoring, maximum 15 daysproportion of patient with Invasive cortical depolarization before, during and after detection of a new cerebral lesion.
Evaluation of temporality between Invasive cortical depolarization and detection of a vasospasmduring monitoring, maximum 15 daysproportion of patient with Invasive cortical depolarization before during and after detection of a vasospasm.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026